Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
20,04 USD | +0,78 % | -1,18 % | -14,26 % |
Resumen de negocios
Número de empleados: 56
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jonathan Young
FOU | Founder | 54 | 01/04/17 |
Timothy Rolph
FOU | Founder | 70 | 01/04/17 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/09/18 |
William White
DFI | Director of Finance/CFO | 51 | 01/04/19 |
Chief Tech/Sci/R&D Officer | - | 01/12/20 | |
Investor Relations Contact | - | - | |
Libette Luce
LAW | General Counsel | - | 01/05/22 |
Patrick Lamy
PRN | Corporate Officer/Principal | - | 01/01/23 |
Kitty Yale
PRN | Corporate Officer/Principal | 52 | 01/10/18 |
Arindam Bose
PRN | Corporate Officer/Principal | 71 | 01/01/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Seth Harrison
BRD | Director/Board Member | 63 | 01/01/17 |
Jane Henderson
BRD | Director/Board Member | 59 | 23/04/19 |
Mark Iwicki
CHM | Chairman | 57 | 01/11/18 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/09/18 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 09/06/20 |
Jonathan Young
FOU | Founder | 54 | 01/04/17 |
Judy Chou
BRD | Director/Board Member | 58 | 12/07/21 |
Graham Walmsley
BRD | Director/Board Member | 37 | 01/06/18 |
Yuan Xu
BRD | Director/Board Member | 56 | 22/04/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 69 151 007 | 59 000 851 ( 85,32 %) | 0 | 85,32 % |
Información de la empresa
Akero Therapeutics, Inc.
601 Gateway Boulevard Suite 350
94080-7006, South San Francisco
+650 487 6488
http://www.akerotx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-14,26 % | 1375,41 M | |
-2,55 % | 102 mil M | |
+2,42 % | 96,09 mil M | |
+2,13 % | 22,28 mil M | |
-17,16 % | 21,4 mil M | |
-8,79 % | 18,14 mil M | |
-39,98 % | 17,02 mil M | |
-13,83 % | 16,09 mil M | |
+5,62 % | 13,83 mil M | |
+32,27 % | 11,97 mil M |
- Bolsa de valores
- Acciones
- Acción AKRO
- Empresa Akero Therapeutics, Inc.